Who makes Tranexamic Acid and vitamin K?

Tranexamic Acid and vitamin K is developed by Tanta University.

What development phase is Tranexamic Acid and vitamin K in?

Tranexamic Acid and vitamin K is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Tranexamic Acid and vitamin K

Tanta University · FDA-approved active Small molecule Quality 1/100

At a glance

Generic name	Tranexamic Acid and vitamin K
Sponsor	Tanta University
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Tranxemic Acid and Vitamin K Injection to Control Upper Gastrointestinal Bleeding in Cirrhotic Patients (PHASE4)
Effect of TXA Oral Sol 5% in Patients Treated With DOACs or VKA and Undergoing a Single or Multiple Tooth Extraction (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Tranexamic Acid and vitamin K CI brief — competitive landscape report
Tranexamic Acid and vitamin K updates RSS · CI watch RSS
Tanta University portfolio CI